Checkpoint inhibitor has been approved to treat locally advanced cutaneous squamous cell carcinoma More: Keytruda gains expanded US approval in skin cancer Source: News
read moreBill has been formally introduced to Parliament this week More: Newly introduced Health and Care Bill aims to ‘dispose of unnecessary bureaucracy’ Source: News
read moreDuring the event, the panel explored how partnerships innovated in the face of challenges More: ‘What’s next for patient advocacy?’ Leaders share lessons of Patient Partnership Index 2021 at free virtual event Source: News
read moreEli Lilly and Boehringer Ingelheim have revealed positive results from a Phase III study of Jardiance in HFpEF patients More: Jardiance becomes first SGLT2 inhibitor to show benefit in HFpEF Source: News
read moreNew ‘Life Sciences Vision’ outlines seven critical healthcare missions More: Gov’t sets out ten-year strategy for the UK’s life sciences sector Source: News
read moreEmergent’s hurting after a tough few months in its COVID-19 vaccine effort. Now, investors are piling on kdunleavy Wed, 07/07/2021 – 00:12 More: Emergent's hurting after a tough few months in its COVID-19 vaccine effort. Now, investors are piling on
read more© 1994 - 2026 B.M. Pharmaceuticals